Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase NA 4Phase 3 4Phase 4 3Phase 1/2 3Phase 1 3Phase 2/3 1

Status

Terminated 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 139Lymphoid 60Other hematologic neoplasm 41Genitourinary 8Gastrointestinal 6Myeloid 5CNS 5Tumor-Agnostic 4Other solid neoplasm 4Dermatologic 4Sarcoma 3Breast 3Thoracic 2Head & Neck 2Gynecologic 1Endocrine 1Classical hematology 1

Conditions

Breast Neoplasms 2Triple Negative Breast Neoplasms 1Prostatic Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1

Interventions

Paclitaxel 100Trastuzumab 81pembrolizumab 76Fulvestrant 68Cyclophosphamide 66Carboplatin 47Capecitabine 47Docetaxel 45palbociclib 41Lapatinib 40Letrozole 37Doxorubicin 29olaparib 28Taxes 28Nivolumab 25Magnetic Resonance Spectroscopy 25Gemcitabine 25130-nm albumin-bound paclitaxel 25Everolimus 23Biopsy 23ribociclib 22abemaciclib 21Specimen Handling 21Albumin-Bound Paclitaxel 21Radiotherapy 19Cisplatin 19Bevacizumab 19Ado-Trastuzumab Emtansine 19pertuzumab 17Alpelisib 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Dexamethasone × Breast × Clear all
NCT02776436 2026-02-17

REDEX

Leiden University Medical Center

Phase 1 Completed
46 enrolled
BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT07341867 2026-01-14

Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype

Dana-Farber Cancer Institute

Phase 1 Not yet recruiting
90 enrolled
BreastPlasma cell

Multiple Myeloma, Triple Negative Breast Neoplasms

NCT00253318 2025-04-27

RAD001 Plus Docetaxel in Patients With Metastatic Breast Cancer

M.D. Anderson Cancer Center

Phase 1 Terminated
15 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡